Schiff Andrew N
CIK 0001172252
Director10% Owner
Filings
12
Latest Jun 16, 2025
Issuers covered
3
Showing
12 of 12
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +3.5% | +3.5% | +3.5% | +3.5% |
| 90 days | 1 | 100% | +7.8% | +7.8% | +7.8% | +7.8% |
| 180 days | 1 | 0% | -3.6% | -3.6% | -3.6% | -3.6% |
| 365 days | 1 | 100% | +32.0% | +32.0% | +32.0% | +32.0% |
Issuers
Companies where Schiff Andrew N has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | 6 | Jun 9, 2025 |
| GLUE | Monte Rosa Therapeutics, Inc. | 4 | Jun 16, 2025 |
| ELEV | Elevation Oncology, Inc. | 2 | Jun 21, 2023 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|